![]() |
|
|
Forward to a colleague |
||
Sponsored Message ![]() Bionas® 2500 measures multiple metabolic parameters simultaneously like acidification, oxygen consumption and adhesion of living cells. Metabolic and cytotoxic effects can be visualized as changes of these parameters in dependence of test compounds... Click Here Access Full Stories Remarkably, despite being over 25 years into the HIV/AIDS epidemic, scientists still don't have an answer to the seemingly simple question: how does HIV cause AIDS?... Read Merck bulks up cardiovascular pipeline Merck & Co. is to bolster its late-stage cardiovascular pipeline through the acquisition of US-based pharma company NovaCardia... Read MDS Pharma expands services in EU market MDS Pharma Services has announced it is expanding its development and regulatory services (DRS) business in Europe while its bioanalytical operations are still struggling. ... Read HIV therapy leads way in personalised medicine GlaxoSmithKline (GSK) has opened the flood gates into the world of personalised medicine with the world's first ever approved genetic test, which predicts a life threatening side effect of one of its antiretroviral... Read PADI dives into the chemical analysis of solids UK researchers have developed a new way to make compounds fly into a mass spectrometer (MS) that could provide benefits for researchers working in drug discovery and quality control (QC) laboratories... Read |
||||||||||
All News Headlines for: August | July | June |
||||||||||
![]() A revolution in Sales Lead Generation! - Free Download Promote your products and technology towards our readers, and we'll build a detailed profile of each person who reads your presentation document... Download our FREE Smart Lead Generation brochure now!... Click Here |
||||||||||
|
Related Industry News Lonza pushes biopharma portfolio Switzerland-based Lonza is establishing its biopharma portfolio with the acquisition of Zyentia's Aggresolve technology this week... Read Illuminating the future of drug delivery Irish researchers have developed a technique that could be used to deliver controlled amounts of drugs to diseased tissues while minimising side effects simply by shining light on the target... Read Kendle's Charles River Labs buyout clouds Q2 A charge due to the acquisition of a Charles River Laboratories' unit a year ago has put a cloud on Kendle's Q2 otherwise all-time high performance... Read Latest twists and turns in Inyx saga The latest twists and turns in the Inyx Inc. bankruptcy saga include an attempted power seize by its creditor, fraud allegations thrown around courtrooms and in the media, the resignation of Inyx' accountants,... Read
|
||||||||||
|
|||
Forward to a colleague |
|||
To continue to receive this newsletter in your inbox, please add newsletter@DrugResearcher.com to your address book |
||
Update preferences | Change your email address | Unsubscribe |
||
Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback |
||
| © 2007 - Decision News Media S.A.S - All Rights Reserved La Tour du Triangle - 26, allee Jules Milhau - 34000 Montpellier - France http://www.decisionnewsmedia.com |
||